Autopsy report · NCT00488384

Acitretin Plasma Levels Under Hemodialysis

“lack of subjects”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Günther Hofbauer

Sponsor type

University, hospital or other

Conditions

Carcinoma, Squamous Cell

Interventions

Chemopreventive application (Acitretin)

Participants

0

Sites

1

Countries

Switzerland

Trials that died the same way

• Cognitive Processing in Patients Surviving Delirium. Neuropsychological, EEG and Structural Brain Correlates.
  “Not enough subjects.” (81% match in meaning)
• Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
  “Lack of eligible subjects.” (81% match in meaning)
• Modified Functional Magnetic Stimulation Treatment for Constipation Improvement
  “no sufficient subjects” (78% match in meaning)
• Effectiveness of Dry Needling of the Sternocleidomastoid in Patients With Cervicogenic Headaches
  “Not enough viable subjects” (77% match in meaning)
• Infliximab Top-down in Pediatric Crohn
  “Not enough study subjects” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.